Effect of Heterologous Vaccination Strategy on Humoral Response against COVID-19 with CoronaVac plus BNT162b2: A Prospective Cohort Study

This study aimed to evaluate the mixed and homogeneous application of the inactivated SARS-CoV-2 vaccine CoronaVac (CV) and the mRNA vaccine BNT162b2 (BNT). This prospective cohort study included 235 health care workers who had received two prime shots with CoronaVac. They were divided into three co...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Hakan Demirhindi, Burak Mete, Ferdi Tanir, Ertan Kara, Filiz Kibar, Salih Cetiner, Aslihan Candevir, Sukriye Ece Akti
Format:	Artigo
Sprog:	Inglês
Udgivet:	MDPI AG 2022-04-01
Serier:	Vaccines
Fag:	COVID-19 vaccines seroconversion inactivated SARS-CoV2 vaccine BNT162 vaccine COVID-19 vaccine booster shot heterologous vaccination
Online adgang:	https://www.mdpi.com/2076-393X/10/5/687
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!